Celadon Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Celadon Pharmaceuticals's balance sheet done over the years? Its assets were worth $9,221,000 last year, which is less than in the previous period. 66% of Celadon Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $6,040,000, which means an decrease by -3% compared compared to last year.

Debt to Assets

Celadon Pharmaceuticals Plc (LSE:CEL.L): Debt to assets
2019 2488745 2.60M 104.56%
2020 3851046 3.75M 97.43%
2021 6607915 197.22K 2.98%
2022 13251000 6.21M 46.89%
2023 9221000 6.04M 65.5%

CEL.L Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
1.25M5.06M4.46M299.47K1.48K
Short term investments
00000
Net receivables
75K1.06M2.13M5995.64K
Inventory
100K20K2K427.94K-14.56K
Other current assets
1.06M186K10.30K9.18K10.02K
Total current assets
2.5M6.33M6.60M737.20K2.59K
Non-current assets:
Property, Plant and Equipment
6.17M6.27M3.30M3.03M2.48M
Goodwill
80K80K719K80.29K0
Intangible assets
248K348K448K00
Long term investments
218K218K200K00
Other non-current assets
0218K-4.67M-3.11M-2.48M
Total non-current assets
6.72M6.92M4.67M3.11M2.48M
Total assets
9.22M13.25M6.60M3.85M2.48M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00-7.25M570.11K0
Short term debt
74K66K7.09M6.66K0
Total current liabilities
955K1.19M176.92K834.86K66.82K
Non-current liabilities:
Long term debt
4.64M4.56M4.48M2.91M2.53M
Deferred tax
00000
Other non-current liabilities
405K389K-4.46M10
Total non-current liabilities
5.08M5.01M20.29K2.91M2.53M
Total liabilities
6.04M6.21M197.22K3.75M2.60M
Data sourceData sourceData sourceData sourceData source